Information Library
Results for: Oncology - Phase I/IIa - Central Laboratories
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Genomics Fact Sheet
Brochure — June 17, 2011
Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. -
Podcast: Changing the Face of Cancer Research
Hear from the Experts — August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Podcast: Changing the Face of Cancer Research
Hear from the Experts — August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Validated Biomarker Menu
Brochure — July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.
Page 1 of 1 (5 results)
